Lapatinib Active Not Recruiting Phase 2 Trials for Head and Neck Carcinoma / Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01612351Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery